Latest Expert Exchange Queries

GST Demo Service software link: https://ims.go2customer.com
Username: demouser Password: demopass
Get your inventory and invoicing software GST Ready from Binarysoft info@binarysoft.com
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
 
 
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing | GST - Goods and Services Tax
 
 
 
 
Popular Search: ACCOUNTING STANDARD :: VAT Audit :: due date for vat payment :: empanelment :: ARTICLES ON INPUT TAX CREDIT IN VAT :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes :: TAX RATES - GOODS TAXABLE @ 4% :: list of goods taxed at 4% :: ACCOUNTING STANDARDS :: form 3cd :: Central Excise rule to resale the machines to a new company :: TDS :: VAT RATES :: articles on VAT and GST in India :: cpt
 
 
Customs and Excise »
 Customs And Central Excise Drawback – Part II
 Customs Valuation (Determination of Value of Imported Goods) Rules 2007
 Amendment to Customs Valuation Rules – Notification No. 91/2017 (NT)
 GST on Custom House Agents
 The Customs and Central Excise Duties Drawback Rules, 2017 and All Industry Rates (AIRs) of Drawback related changes
 The Customs and Central Excise Duties Drawback Rules, 2017
 Man fleeing from Customs arrested
 Refund of amount on account of double-payment of Customs
 SC paves way for trial against RIL in 1987 excise evasion case
 GST: Govt sets up panel to receive profiteering complaints
 IGST on high-seas sale of imports is levied only during customs clearance

CBECs imposes excise duty
March, 04th 2010

The decision of the Central Board of Excise and Customs (CBEC) to uphold its stand on imposing excise duty for free drug samples through valuation based on the maximum retail price (MRP) has raised serious objections from the pharma industry.

The CBEC, through a circular dated February 19, 2010, reiterated that the value for excise duty on free samples should be determined under Rule 4 of the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000.

The decision will affect the industry once the tax exemption enjoyed by the northern states comes to an end, said N R Munjal, president, Indian Drug Manufacturers Association (IDMA). The Association is planning to discuss the issue in its executive committee meeting scheduled on March 19, 2010, at Chandigarh and to finalise the further action to be taken in this regard.

The CBEC's decision is based on the earlier decisions of the Customs, Excise and Service Tax Appellate Tribunal (CESTAT) in the Blue Cross Laboratories vs CCE, Mumbai dispute, in 2006 and the Cadila Pharmaceuticals Ltd vs Commissioner of Central Excise Ahmedabad II, in 2008. The Board, in its new circular, also clarifies that a circular in 2005 clarifying its stand on excise duty on free drug samples has been upheld by High Court of Mumbai in the case of Indian Drugs Manufacturer's Association vs. UOI, in 2008.

"CESTAT in its majority decision in the case of Cadila Pharmaceuticals Ltd. vs Commissioner of Central Excise Ahmedabad II, reported at 2008 (232) ELT 0245 (Tri.-LB), has held that even after the pharmaceutical products have been notified for MRP assessment under Section 4A of the Central Excise Act, the assessment of free physician samples of these products , is appropriately required to be done under Rule 4 of the valuation rules by taking into consideration the deemed value under Section 4A(1) notwithstanding the non availability of normal price under Section 4(1)(a) of the Act, ibid.

Accordingly, the value for payment of excise duty for physician sample would be the value determined under Section 4A for the similar goods (subject to adjustment for size & pack etc.)," details the circular.

The new circular, concludes that the "...decision of CESTAT would, mutatis mutandis, be applicable in respect of free samples of other products which are under MRP assessment. Accordingly, it is clarified that valuation of Samples which are distributed free as part of marketing strategy, or as gifts or donations, shall be determined, in terms of Board's circular No. 813/10/2005-CX dated 25.4.2005 and the aforesaid decisions of CESTAT, as explained in foregoing paras 2 & 3, whether the final products are assessed under MRP based assessment or otherwise."

However, the decision to collect duty on drug samples which the companies are distributing absolutely for free is unreasonable, said Munjal. "Earlier, the duty was charged only if the product is a saleable pack. Four per cent of the total sales revenue was under exemption for new products introduced in the market," he maintained. The imposition of duty on free samples may not turnout be a major issue at present as majority of products are manufactured in the tax free zones in Northern India and the value could not be calculated.

Once the tax exemption gets withdrawn in these states, pharma companies in the country may experience the impact of the decision. Munjal said that the Association will finalize its course of action objecting to the decision to the government in the meeting in Chandigarh.

 
 
Home | About Us | Terms and Conditions | Contact Us
Copyright 2017 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Binarysoft Technologies - Privacy Policy

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions